Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Defective efficacy of retinoic Acid treatment in patients with metastatic thyroid carcinoma.

Defective efficacy of retinoic Acid treatment in patients with metastatic thyroid carcinoma. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Defective efficacy of retinoic Acid treatment in patients with metastatic thyroid carcinoma. Abstract Text:

    f courbonF Courbon,s zerdoudS Zerdoud,d bastieD Bastie,fr archambaudFr Archambaud,m hoffM Hoff,n echeN Eche,i berryI Berry,ph caronPh Caron,

    Radioiodine (I-131) therapy is of proven efficacy for differentiated thyroid carcinoma. However, its efficacy relies on specific uptake mechanisms, which may be lost during the evolution of the disease. Attempts to increase the iodine uptake of such tumors have been made using retinoic acid because it exerts redifferentiating effects on thyrocytes. This study aims to assess the capability of the retinoic acid (RA) treatment to reinforce iodine 131-irradiation efficacy for metastatic and progressive multi-irradiated thyroid cancer. In this clinical prospective study, 11 patients (mean age +/- 1 SD = 61 +/- 12 years, sex ratio M/F = 5/6) with a progressive disease despite iterative surgery and iodine irradiations were treated with 13-cis-retinoic acid (1.5 mg/kg day) over 8 weeks prior to I-131 irradiation. The redifferentiating effect of RA was evaluated by serum thyroglobulin (Tg) monitoring during RA treatment and qualitative analysis of iodine uptake on the post-therapeutic whole body scan. The clinical usefulness of RA treatment was assessed by clinical follow-up, Tg monitoring, and tumor size. No serious event that could possibly be related to the treatment was reported. The mean follow up time was 24.2 +/- 12 months (range 3-46 months). Iodine uptake was only slightly improved in two patients. Nevertheless, the clinical benefits of RA seem to be very poor. Five patients died of a metastatic disease. Five others presented new clinical evidences of a progressive disease. In conclusion, this prospective study demonstrates the absence of efficacy of I-131 irradiation combined with RA for the treatment of patients with aggressive, rapidly growing metastatic thyroid cancer. Thus, patients with highly aggressive disease, rapidly growing in a short period from 2 to 6 months, should not be considered for RA therapy.

    Defective efficacy of retinoic Acid treatment in patients with metastatic thyroid carcinoma. Publishing Authors By Initials

    f courbonF Courbon,s zerdoudS Zerdoud,d bastieD Bastie,f archambaudF Archambaud,m hoffM Hoff,n echeN Eche,i berryI Berry,p caronP Caron,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Defective efficacy of retinoic Acid treatment in patients with metastatic thyroid carcinoma. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Thyroid : official journal of the American Thyroid

    VOLUME: 16

    Page Numbers: 1025-31

    Journal Abbreviation: Thyroid

    ISSN: 1050-7256

    DAY: 17

    MONTH: Oct

    YEAR: 2006

    Defective efficacy of retinoic Acid treatment in patients with metastatic thyroid carcinoma. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9104317

    Defective efficacy of retinoic Acid treatment in patients with metastatic thyroid carcinoma. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Defective efficacy of retinoic Acid treatment in patients with metastatic thyroid carcinoma. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Defective efficacy of retinoic Acid treatment in patients with metastatic thyroid carcinoma.

    AFFILIATION: Department of Nuclear Medicine, University Hospital Toulouse Rangueil 1, Toulouse, France.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Thyroid

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Defective efficacy of retinoic Acid treatment in patients with metastatic thyroid carcinoma Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News